377 related articles for article (PubMed ID: 25992435)
21. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
22. Multi-Functionalized Nanomaterials and Nanoparticles for Diagnosis and Treatment of Retinoblastoma.
Arshad R; Barani M; Rahdar A; Sargazi S; Cucchiarini M; Pandey S; Kang M
Biosensors (Basel); 2021 Mar; 11(4):. PubMed ID: 33810621
[TBL] [Abstract][Full Text] [Related]
23. A light-controllable specific drug delivery nanoplatform for targeted bimodal imaging-guided photothermal/chemo synergistic cancer therapy.
Guo Y; Wang XY; Chen YL; Liu FQ; Tan MX; Ao M; Yu JH; Ran HT; Wang ZX
Acta Biomater; 2018 Oct; 80():308-326. PubMed ID: 30240955
[TBL] [Abstract][Full Text] [Related]
24. Nanomedicine-nanoscale drugs and delivery systems.
Singh S
J Nanosci Nanotechnol; 2010 Dec; 10(12):7906-18. PubMed ID: 21121278
[TBL] [Abstract][Full Text] [Related]
25. Importance of integrating nanotechnology with pharmacology and physiology for innovative drug delivery and therapy - an illustration with firsthand examples.
Zhang RX; Li J; Zhang T; Amini MA; He C; Lu B; Ahmed T; Lip H; Rauth AM; Wu XY
Acta Pharmacol Sin; 2018 May; 39(5):825-844. PubMed ID: 29698389
[TBL] [Abstract][Full Text] [Related]
26. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
[TBL] [Abstract][Full Text] [Related]
28. The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field.
Chandler M; Johnson B; Khisamutdinov E; Dobrovolskaia MA; Sztuba-Solinska J; Salem AK; Breyne K; Chammas R; Walter NG; Contreras LM; Guo P; Afonin KA
ACS Nano; 2021 Nov; 15(11):16957-16973. PubMed ID: 34677049
[TBL] [Abstract][Full Text] [Related]
29. Polymer nanotechnology based approaches in mucosal vaccine delivery: challenges and opportunities.
Sharma R; Agrawal U; Mody N; Vyas SP
Biotechnol Adv; 2015; 33(1):64-79. PubMed ID: 25499178
[TBL] [Abstract][Full Text] [Related]
30. Cancer Nanotechnology: Opportunities for Prevention, Diagnosis, and Therapy.
Zeineldin R; Syoufjy J
Methods Mol Biol; 2017; 1530():3-12. PubMed ID: 28150193
[TBL] [Abstract][Full Text] [Related]
31. Biomedical Applications of Magnetically Functionalized Organic/Inorganic Hybrid Nanofibers.
Lee HJ; Lee SJ; Uthaman S; Thomas RG; Hyun H; Jeong YY; Cho CS; Park IK
Int J Mol Sci; 2015 Jun; 16(6):13661-77. PubMed ID: 26084046
[TBL] [Abstract][Full Text] [Related]
32. Nanotechnology for nanomedicine and delivery of drugs.
Venugopal J; Prabhakaran MP; Low S; Choon AT; Zhang YZ; Deepika G; Ramakrishna S
Curr Pharm Des; 2008; 14(22):2184-200. PubMed ID: 18781971
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and Therapeutic Nanomedicine.
Joo J
Adv Exp Med Biol; 2021; 1310():401-447. PubMed ID: 33834444
[TBL] [Abstract][Full Text] [Related]
34. Bifunctional submicron colloidosomes coassembled from fluorescent and superparamagnetic nanoparticles.
Bollhorst T; Shahabi S; Wörz K; Petters C; Dringen R; Maas M; Rezwan K
Angew Chem Int Ed Engl; 2015 Jan; 54(1):118-23. PubMed ID: 25370462
[TBL] [Abstract][Full Text] [Related]
35. An Overview of Chitosan Nanofibers and their Applications in the Drug Delivery Process.
Al-Jbour ND; Beg MD; Gimbun J; Alam AKMM
Curr Drug Deliv; 2019; 16(4):272-294. PubMed ID: 30674256
[TBL] [Abstract][Full Text] [Related]
36. Safety and Toxicological Considerations of Nanomedicines: The Future Directions.
Patel P; Shah J
Curr Clin Pharmacol; 2017; 12(2):73-82. PubMed ID: 28486906
[TBL] [Abstract][Full Text] [Related]
37. Special Issue "Recent Advances in Precision Nanomedicine for Cancer".
Brignole C; Pastorino F
Molecules; 2020 Sep; 25(18):. PubMed ID: 32927825
[TBL] [Abstract][Full Text] [Related]
38. Nano-sized platforms for vaginal drug delivery.
El-Hammadi MM; Arias JL
Curr Pharm Des; 2015; 21(12):1633-44. PubMed ID: 25354177
[TBL] [Abstract][Full Text] [Related]
39. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
40. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics.
Vangijzegem T; Stanicki D; Laurent S
Expert Opin Drug Deliv; 2019 Jan; 16(1):69-78. PubMed ID: 30496697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
